184 related articles for article (PubMed ID: 1706681)
1. Antigen recognition and peptide-mediated immunotherapy in autoimmune disease.
Smilek DE; Lock CB; McDevitt HO
Immunol Rev; 1990 Dec; 118():37-71. PubMed ID: 1706681
[No Abstract] [Full Text] [Related]
2. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.
Wraith DC; Smilek DE; Mitchell DJ; Steinman L; McDevitt HO
Cell; 1989 Oct; 59(2):247-55. PubMed ID: 2478291
[TBL] [Abstract][Full Text] [Related]
3. TCR peptide therapy in autoimmune diseases.
Vandenbark AA; Hashim G; Offner H
Int Rev Immunol; 1993; 9(4):251-76. PubMed ID: 7683708
[No Abstract] [Full Text] [Related]
4. EAE: a model for immune intervention with synthetic peptides.
Smilek DE; Gautam AM; Pearson C; Steinman L; McDevitt HO
Int Rev Immunol; 1992; 9(3):223-30. PubMed ID: 1285062
[TBL] [Abstract][Full Text] [Related]
5. A role for major histocompatibility complex-binding peptides in the immunotherapy of autoimmune disease.
Wraith DC; Smilek DE
Springer Semin Immunopathol; 1992; 14(1):95-101. PubMed ID: 1440200
[No Abstract] [Full Text] [Related]
6. The use of MHC-binding peptides in the immunotherapy of autoimmune diseases: a commentary.
Wraith DC
Res Immunol; 1991; 142(5-6):505-8. PubMed ID: 1754726
[No Abstract] [Full Text] [Related]
7. The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease.
Steinman L
Adv Immunol; 1991; 49():357-79. PubMed ID: 1713016
[No Abstract] [Full Text] [Related]
8. Modulation of the immune response with T-cell epitopes: the ultimate goal for specific immunotherapy of autoimmune disease.
Fairchild PJ; Thorpe CJ; Travers PJ; Wraith DC
Immunology; 1994 Apr; 81(4):487-96. PubMed ID: 7518791
[No Abstract] [Full Text] [Related]
9. MHC-binding peptides for immunotherapy of experimental autoimmune disease.
Wraith DC; Smilek DE; Webb S
J Autoimmun; 1992 Apr; 5 Suppl A():103-13. PubMed ID: 1380239
[TBL] [Abstract][Full Text] [Related]
10. Autoantigenic peptide therapy in experimental autoimmune encephalomyelitis.
Wraith DC
Immunol Ser; 1993; 59():345-57. PubMed ID: 7681697
[No Abstract] [Full Text] [Related]
11. Development of antigen-specific therapies for autoimmune disease.
Steinman L
Mol Biol Med; 1990 Aug; 7(4):333-9. PubMed ID: 2233245
[TBL] [Abstract][Full Text] [Related]
12. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
Sharma SD; Nag B; Su XM; Green D; Spack E; Clark BR; Sriram S
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11465-9. PubMed ID: 1722335
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex.
Aharoni R; Teitelbaum D; Arnon R; Puri J
Nature; 1991 May; 351(6322):147-50. PubMed ID: 1709449
[TBL] [Abstract][Full Text] [Related]
14. Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.
Bai XF; Link H
Clin Exp Allergy; 2000 Dec; 30(12):1688-96. PubMed ID: 11122206
[No Abstract] [Full Text] [Related]
15. Cytotoxic T cells in autoimmune disease of the central nervous system.
Sun D; Meyermann R; Wekerle H
Ann N Y Acad Sci; 1988; 532():221-9. PubMed ID: 2460009
[No Abstract] [Full Text] [Related]
16. Treatment of autoimmune diseases by oral tolerance to autoantigens.
Weiner HL; Miller A; Khoury SJ; Zhang ZJ; al-Sabbagh A; Brod SA; Lider O; Higgins P; Sobel R; Matsui M
Adv Exp Med Biol; 1995; 371B():1217-23. PubMed ID: 7502787
[No Abstract] [Full Text] [Related]
17. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.
Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9470-4. PubMed ID: 2480602
[TBL] [Abstract][Full Text] [Related]
18. Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.
Zamvil SS; Mitchell DJ; Powell MB; Sakai K; Rothbard JB; Steinman L
J Exp Med; 1988 Sep; 168(3):1181-6. PubMed ID: 2459291
[TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental autoimmune encephalomyelitis by encephalitogenic epitope sequence simplified derivatives.
Marino M; Ippolito A; Ruvo M; Scarallo A; Volpe S; Fassina G
Mol Immunol; 2000 Nov; 37(16):951-60. PubMed ID: 11395134
[TBL] [Abstract][Full Text] [Related]
20. Approaches toward peptide-based immunotherapy of autoimmune diseases.
Adorini L; Guéry JC; Trembleau S
Springer Semin Immunopathol; 1992; 14(2):187-99. PubMed ID: 1475744
[No Abstract] [Full Text] [Related]
[Next] [New Search]
